Replies to post #7721 on RespireRx Pharmaceuticals Inc (fka RSPI)

[gfp927z]

Jim, Sorry for being such a bore :o) I find that writing helps me get things straight in my mind. My memory ain't what it used to be though, so I end up being repetitive. I'm starting to make more at investing than via regular work however, so maybe it's beginning to pay off. I guess we could always publish my posts as a sleep aid for insomniacs :o)

[zebra4o1]

Jim, somebody needs to make a biotech dilution web site, on the lines of the 'mortgage lender implodometer' site. A couple of times I have tried to make a graph of market cap and stock price versus time for my biotechs. But it is hard to get the historical data on what the float was at various times in the past.

Anyway, it is facinating to see the stock price of a biotech (like Cortex) essentially flat for years, while the total market cap of the company increases due to dilution. Biotech is a race between dilution and clinical progress/partnerships. We tend to focus too much on the clinical progress and partnerships when that is only have of the story.

Of course the other way to view small cap biotechs is as non-expiring options on the potential success the pipeline. So maybe from that perspective dilution is the price you pay for having your option not expire.

[zebra4o1]

Speaking of dilution, aren't we due for raising some cash soon? Unless they can do a partnership very soon, they are going to have to do a placement, right? And there is always that argument about negotiating from strength. Or maybe they are getting enough from warrants to hold out for a while?

Feel like a basher bringing this up. But this market has me spooked.